These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 30334197

  • 1. The impact of isolated maternal hypothyroxinemia during the first and second trimester of gestation on pregnancy outcomes: an intervention and prospective cohort study in China.
    Gong X, Liu A, Li Y, Sun H, Li Y, Li C, Yu X, Fan C, Shan Z, Teng W.
    J Endocrinol Invest; 2019 May; 42(5):599-607. PubMed ID: 30334197
    [Abstract] [Full Text] [Related]

  • 2. Iron Deficiency May Predict Greater Risk for Hypothyroxinemia: A Retrospective Cohort Study of Pregnant Women in China.
    Teng X, Shan Z, Li C, Yu X, Mao J, Wang W, Xie X, Du J, Zhang S, Gao Z, Zhang X, Li L, Fan C, Teng W.
    Thyroid; 2018 Aug; 28(8):968-975. PubMed ID: 29968513
    [Abstract] [Full Text] [Related]

  • 3. Isolated maternal hypothyroxinemia and adverse pregnancy outcomes: A systematic review.
    Ramezani Tehrani F, Nazarpour S, Behboudi-Gandevani S.
    J Gynecol Obstet Hum Reprod; 2021 Sep; 50(7):102057. PubMed ID: 33401029
    [Abstract] [Full Text] [Related]

  • 4. The Interactive Effect of Prepregnancy Overweight/Obesity and Isolated Maternal Hypothyroxinemia on Macrosomia.
    Liu Y, Guo F, Zhou Y, Yang X, Zhang Y, Fan J.
    J Clin Endocrinol Metab; 2021 Jun 16; 106(7):e2639-e2646. PubMed ID: 33720320
    [Abstract] [Full Text] [Related]

  • 5. Association between isolated maternal hypothyroxinemia during the first trimester and adverse pregnancy outcomes in Southern Chinese women: a retrospective study of 7051 cases.
    Li P, Cui J, Li L, Chen X, Ouyang L, Fan J, Lin S.
    BMC Pregnancy Childbirth; 2022 Nov 23; 22(1):866. PubMed ID: 36424562
    [Abstract] [Full Text] [Related]

  • 6. Isolated effect of maternal thyroid-stimulating hormone, free thyroxine and antithyroid peroxidase antibodies in early pregnancy on gestational diabetes mellitus: a birth cohort study in China.
    Huang K, Xu Y, Yan S, Li T, Xu Y, Zhu P, Tao F.
    Endocr J; 2019 Mar 28; 66(3):223-231. PubMed ID: 30674732
    [Abstract] [Full Text] [Related]

  • 7. The impact of isolated maternal hypothyroxinaemia on the incidence of large-for-gestational-age infants: the Ma'anshan Birth Cohort study.
    Zhu YD, Han Y, Huang K, Zhu BB, Yan SQ, Ge X, Zhou SS, Xu YY, Ren LI, Sheng J, Pan WJ, Hao JH, Zhu P, Tao FB.
    BJOG; 2018 Aug 28; 125(9):1118-1125. PubMed ID: 29266657
    [Abstract] [Full Text] [Related]

  • 8. Maternal thyroid hypofunction and pregnancy outcome.
    Cleary-Goldman J, Malone FD, Lambert-Messerlian G, Sullivan L, Canick J, Porter TF, Luthy D, Gross S, Bianchi DW, D'Alton ME.
    Obstet Gynecol; 2008 Jul 28; 112(1):85-92. PubMed ID: 18591312
    [Abstract] [Full Text] [Related]

  • 9. Early Levothyroxine Treatment for Subclinical Hypothyroidism or Hypothyroxinemia in Pregnancy: The St Carlos Gestational and Thyroid Protocol.
    Runkle I, de Miguel MP, Barabash A, Cuesta M, Diaz Á, Duran A, Familiar C, de la Torre NG, Herraiz MÁ, Izquierdo N, Diaz Á, Marcuello C, Matia P, Melero V, Montañez C, Moraga I, Perez-Ferre N, Perez N, Assaf-Balut C, Rubio MÁ, Ruiz-Sanchez JG, Sanabria C, Torrejon MJ, Valerio J, Del Valle L, Calle-Pascual A.
    Front Endocrinol (Lausanne); 2021 Jul 28; 12():743057. PubMed ID: 34737722
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Maternal hypothyroxinemia in the first trimester of gestation and association with obstetric and neonatal outcomes and iron deficiency: a prospective Brazilian study.
    Rosario PW, Oliveira LFF, Calsolari MR.
    Arch Endocrinol Metab; 2018 Jun 28; 62(3):332-336. PubMed ID: 29791654
    [Abstract] [Full Text] [Related]

  • 12. The Association Between Isolated Maternal Hypothyroxinemia in Early Pregnancy and Preterm Birth.
    Yang X, Yu Y, Zhang C, Zhang Y, Chen Z, Dubois L, Huang HF, Fraser WD, Fan J.
    Thyroid; 2020 Dec 28; 30(12):1724-1731. PubMed ID: 32434441
    [Abstract] [Full Text] [Related]

  • 13. Perinatal significance of isolated maternal hypothyroxinemia identified in the first half of pregnancy.
    Casey BM, Dashe JS, Spong CY, McIntire DD, Leveno KJ, Cunningham GF.
    Obstet Gynecol; 2007 May 28; 109(5):1129-35. PubMed ID: 17470594
    [Abstract] [Full Text] [Related]

  • 14. Association of maternal mild hypothyroidism in the first and third trimesters with obstetric and perinatal outcomes: a prospective cohort study.
    Liu X, Zhang C, Lin Z, Zhu K, He R, Jiang Z, Wu H, Yu J, Luo Q, Sheng J, Fan J, Pan J, Huang H.
    Am J Obstet Gynecol; 2024 Aug 30. PubMed ID: 39218287
    [Abstract] [Full Text] [Related]

  • 15. Levothyroxine dose adjustment in hypothyroid women achieving pregnancy through IVF.
    Busnelli A, Vannucchi G, Paffoni A, Faulisi S, Fugazzola L, Fedele L, Somigliana E.
    Eur J Endocrinol; 2015 Oct 30; 173(4):417-24. PubMed ID: 26139211
    [Abstract] [Full Text] [Related]

  • 16. Frequency of isolated maternal hypothyroxinemia in women with gestational diabetes mellitus in a moderately iodine-deficient area.
    Oguz A, Tuzun D, Sahin M, Usluogullari AC, Usluogullari B, Celik A, Gul K.
    Gynecol Endocrinol; 2015 Oct 30; 31(10):792-5. PubMed ID: 26190538
    [Abstract] [Full Text] [Related]

  • 17. Maternal hypothyroidism in early and late gestation: effects on neonatal and obstetric outcome.
    Idris I, Srinivasan R, Simm A, Page RC.
    Clin Endocrinol (Oxf); 2005 Nov 30; 63(5):560-5. PubMed ID: 16268809
    [Abstract] [Full Text] [Related]

  • 18. Effects of isolated maternal hypothyroxinemia on adverse pregnancy outcomes.
    Nazarpour S, Ramezani Tehrani F, Rahmati M, Amiri M, Azizi F.
    Arch Gynecol Obstet; 2022 Apr 30; 305(4):903-911. PubMed ID: 34482473
    [Abstract] [Full Text] [Related]

  • 19. Association of maternal thyroid function with birthweight: a systematic review and individual-participant data meta-analysis.
    Derakhshan A, Peeters RP, Taylor PN, Bliddal S, Carty DM, Meems M, Vaidya B, Chen L, Knight BA, Ghafoor F, Popova PV, Mosso L, Oken E, Suvanto E, Hisada A, Yoshinaga J, Brown SJ, Bassols J, Auvinen J, Bramer WM, López-Bermejo A, Dayan CM, French R, Boucai L, Vafeiadi M, Grineva EN, Pop VJM, Vrijkotte TG, Chatzi L, Sunyer J, Jiménez-Zabala A, Riaño I, Rebagliato M, Lu X, Pirzada A, Männistö T, Delles C, Feldt-Rasmussen U, Alexander EK, Nelson SM, Chaker L, Pearce EN, Guxens M, Steegers EAP, Walsh JP, Korevaar TIM.
    Lancet Diabetes Endocrinol; 2020 Jun 30; 8(6):501-510. PubMed ID: 32445737
    [Abstract] [Full Text] [Related]

  • 20. Adjustment of L-T4 substitutive therapy in pregnant women with subclinical, overt or post-ablative hypothyroidism.
    Verga U, Bergamaschi S, Cortelazzi D, Ronzoni S, Marconi AM, Beck-Peccoz P.
    Clin Endocrinol (Oxf); 2009 May 30; 70(5):798-802. PubMed ID: 18771569
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.